Composition for treatment of constipation and irritable bowel syndrome
US6734188B1 · kind B1 · utility
64Cited by
2References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 5, 2002 |
| Grant date | May 11, 2004 |
| Priority date | — |
| Expiry date | Aug 5, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Constipation and Irritable Bowel Syndrome are treated by a delayed and sustained release composition of an opioid antagonist which commences release of the opioid antagonist in the mid to distal small intestine or ascending colon and provides sustained release along any remaining part of the small intestine and along the colon. Preferred opioid antagonists are naloxone and naltrexone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.